Entry |
|
Name |
Trilostane (JAN/USAN); Desopan (TN); Modrenal (TN) |
Formula |
C20H27NO3
|
Exact mass |
329.1991
|
Mol weight |
329.4333
|
Structure |
|
Simcomp |
|
Remark |
Therapeutic category: | 2499 |
|
Efficacy |
Antisecretory (hormone), Adrenocortical hormone biosynthesis inhibitor |
Comment |
Androstene derivative
|
Target |
|
Pathway |
hsa04925 | Aldosterone synthesis and secretion |
|
Network |
nt06019 | Steroid hormone biosynthesis |
|
Interaction |
|
Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
H SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS
H02 CORTICOSTEROIDS FOR SYSTEMIC USE
H02C ANTIADRENAL PREPARATIONS
H02CA Anticorticosteroids
H02CA01 Trilostane
D01180 Trilostane (JAN/USAN) <JP>
Therapeutic category of drugs in Japan [BR:br08301]
2 Agents affecting individual organs
24 Hormones
249 Miscellaneous
2499 Others
D01180 Trilostane (JAN/USAN)
Target-based classification of drugs [BR:br08310]
Enzymes
Oxidoreductases (EC1)
Dehydrogenases
HSD3B
D01180 Trilostane (JAN/USAN) <JP>
|
Other DBs |
|
KCF data |
ATOM 24
1 C2y C 21.9478 -18.5968
2 C2y C 21.9478 -19.9662
3 C1x C 23.1401 -17.9120
4 C1z C 24.3252 -18.5968
5 C1x C 25.4984 -20.6561
6 C1x C 26.6906 -19.9765
7 C1y C 25.5103 -17.9171
8 C1y C 26.6906 -18.6100
9 C1x C 26.7135 -15.8782
10 C1x C 25.4518 -16.5514
11 C1z C 27.8869 -16.5712
12 C1y C 27.8771 -17.9326
13 C1x C 30.2816 -17.9151
14 C1x C 30.3217 -16.6003
15 C1y C 29.0777 -15.9048
16 O1a O 29.0945 -14.5357
17 C1a C 27.8845 -15.2013
18 C1a C 24.3126 -17.2273
19 C1z C 24.3892 -19.9662
20 C1y C 23.1392 -20.6513
21 O2x O 24.3314 -21.3317
22 O1a O 20.7656 -20.6512
23 C3b C 20.7658 -17.9113
24 N3a N 19.5688 -17.2202
BOND 28
1 19 5 1
2 5 6 1
3 6 8 1
4 11 12 1
5 13 14 1
6 14 15 1
7 15 11 1
8 12 13 1
9 7 4 1
10 15 16 1 #Up
11 4 3 1
12 11 17 1 #Up
13 3 1 1
14 1 2 2
15 7 8 1
16 4 18 1 #Up
17 8 12 1
18 11 9 1
19 9 10 1
20 19 20 1
21 19 21 1 #Down
22 20 21 1 #Down
23 10 7 1
24 2 22 1
25 2 20 1
26 1 23 1
27 4 19 1
28 23 24 3
|